These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 38792060)

  • 41. Emerging Applications of Metabolomics in Clinical Pharmacology.
    Pang H; Jia W; Hu Z
    Clin Pharmacol Ther; 2019 Sep; 106(3):544-556. PubMed ID: 31173340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Challenges and developments in tandem mass spectrometry based clinical metabolomics.
    Ceglarek U; Leichtle A; Brügel M; Kortz L; Brauer R; Bresler K; Thiery J; Fiedler GM
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):266-71. PubMed ID: 19007853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel strategies for clinical investigation and biomarker discovery: a guide to applied metabolomics.
    Carneiro G; Radcenco AL; Evaristo J; Monnerat G
    Horm Mol Biol Clin Investig; 2019 Jan; 38(3):. PubMed ID: 30653466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolomics-driven discovery of therapeutic targets for cancer cachexia.
    Cui P; Li X; Huang C; Lin D
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):781-793. PubMed ID: 38644205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
    Gu Y; Zang P; Li J; Yan Y; Wang J
    Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
    Peng J; Chen YT; Chen CL; Li L
    Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery.
    Zha H; Cai Y; Yin Y; Wang Z; Li K; Zhu ZJ
    Anal Chem; 2018 Mar; 90(6):4062-4070. PubMed ID: 29485856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolomics: A High-Throughput Platform for Metabolite Profile Exploration.
    Cheng J; Lan W; Zheng G; Gao X
    Methods Mol Biol; 2018; 1754():265-292. PubMed ID: 29536449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolomics: moving to the clinic.
    Nordström A; Lewensohn R
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):4-17. PubMed ID: 19399626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NMR Metabolomics Protocols for Drug Discovery.
    Bhinderwala F; Powers R
    Methods Mol Biol; 2019; 2037():265-311. PubMed ID: 31463851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
    Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
    Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products.
    Vitale GA; Geibel C; Minda V; Wang M; Aron AT; Petras D
    Nat Prod Rep; 2024 Jun; 41(6):885-904. PubMed ID: 38351834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery.
    Patel S; Ahmed S
    J Pharm Biomed Anal; 2015 Mar; 107():63-74. PubMed ID: 25569286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease.
    Wang X; Zhang A; Han Y; Wang P; Sun H; Song G; Dong T; Yuan Y; Yuan X; Zhang M; Xie N; Zhang H; Dong H; Dong W
    Mol Cell Proteomics; 2012 Aug; 11(8):370-80. PubMed ID: 22505723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
    Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
    Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional metabolomics: from biomarker discovery to metabolome reprogramming.
    Peng B; Li H; Peng XX
    Protein Cell; 2015 Sep; 6(9):628-37. PubMed ID: 26135925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High resolution mass spectrometry based techniques at the crossroads of metabolic pathways.
    Junot C; Fenaille F; Colsch B; Bécher F
    Mass Spectrom Rev; 2014; 33(6):471-500. PubMed ID: 24288070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of metabolomics technologies toward cancer prognosis and therapy.
    Hoang G; Udupa S; Le A
    Int Rev Cell Mol Biol; 2019; 347():191-223. PubMed ID: 31451214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analytical Metabolomics and Applications in Health, Environmental and Food Science.
    Fraga-Corral M; Carpena M; Garcia-Oliveira P; Pereira AG; Prieto MA; Simal-Gandara J
    Crit Rev Anal Chem; 2022; 52(4):712-734. PubMed ID: 33026841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell metabolomics.
    Zhang A; Sun H; Xu H; Qiu S; Wang X
    OMICS; 2013 Oct; 17(10):495-501. PubMed ID: 23988149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.